(Q37234094)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Interaction between statins and clopidogrel: is there anything clinically relevant? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

R Bhindi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

O Ormerod

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

J Newton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

L Testa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

QJM: An International Journal of Medicine

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

915-925

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676683%20AND%20SRC:MED&resulttype=core&format=json

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Structural mechanism for statin inhibition of HMG-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Systematic overview of warfarin and its drug and food interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Cerivastatin and reports of fatal rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Are we making efficient use of clopidogrel?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Determination of clopidogrel in human plasma by liquid chromatography/tandem mass spectrometry: application to a clinical pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Existence of a clinically relevant interaction between clopidogrel and HMG-CoA reductase inhibitors? Re-evaluating the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function — a flow cytometry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Not all statins interfere with clopidogrel during antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Do statins really interfere with clopidogrel-induced platelet function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089

Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCN089